These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A, Chua JV, Talwani R, Bentzen SM, Baddley J. Trials; 2020 Oct 28; 21(1):897. PubMed ID: 33115543 [Abstract] [Full Text] [Related]
7. Correction: Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation Correction: After Resuscitation-2 (RADAR-2) randomised clinical trial. Silversides JA, McMullan R, Emerson LM, Bradbury I, Bannard-Smith J, Szakmany T, Trinder J, Rostron AJ, Johnston P, Ferguson AJ, Boyle AJ, Blackwood B, Marshall JC, McAuley DF. Intensive Care Med; 2023 Nov 28; 49(11):1440. PubMed ID: 37642672 [No Abstract] [Full Text] [Related]
9. Bioelectrical impedance analysis during deresuscitation: correlation and agreement with cumulative fluid balance in ICU patients. Ruste M, Chabanol C, Fellahi JL, Jacquet-Lagrèze M. J Clin Monit Comput; 2023 Apr 28; 37(2):679-687. PubMed ID: 36197549 [Abstract] [Full Text] [Related]
10. Phases of fluid management and the roles of human albumin solution in perioperative and critically ill patients. Wiedermann CJ. Curr Med Res Opin; 2020 Dec 28; 36(12):1961-1973. PubMed ID: 33090028 [Abstract] [Full Text] [Related]
11. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Malbrain ML, Marik PE, Witters I, Cordemans C, Kirkpatrick AW, Roberts DJ, Van Regenmortel N. Anaesthesiol Intensive Ther; 2014 Dec 28; 46(5):361-80. PubMed ID: 25432556 [Abstract] [Full Text] [Related]
16. Conservative oxygen therapy for mechanically ventilated adults with sepsis: a post hoc analysis of data from the intensive care unit randomized trial comparing two approaches to oxygen therapy (ICU-ROX). Young P, Mackle D, Bellomo R, Bailey M, Beasley R, Deane A, Eastwood G, Finfer S, Freebairn R, King V, Linke N, Litton E, McArthur C, McGuinness S, Panwar R, ICU-ROX Investigators the Australian New Zealand Intensive Care Society Clinical Trials Group. Intensive Care Med; 2020 Jan 21; 46(1):17-26. PubMed ID: 31748836 [Abstract] [Full Text] [Related]
18. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial. Payares-Herrera C, Martínez-Muñoz ME, Vallhonrat IL, de Molina RM, Torres MP, Trisan A, de Diego IS, Alonso R, Zafra R, Donaire T, Sánchez R, Rubio JJ, Duarte Palomino RF, Solá CA. Trials; 2021 Jan 06; 22(1):9. PubMed ID: 33407777 [Abstract] [Full Text] [Related]